Afficher la couverture '17q21.31 duplication causes prominent tau-related dementia with increased MAPT expression | Le Guennec, K.' en grand format
/5

0 avis

17q21.31 duplication causes prominent tau-related dementia with increased MAPT expression

Archive ouverte

Le Guennec, K. | Quenez, O. | Nicolas, G. | Wallon, D. | Rousseau, S. | Richard, A.-C. | Alexander, J. | Paschou, P. | Charbonnier, C. | Bellenguez, C. | Grenier-Boley, B. | Lechner, D. | Bihoreau, M.-T. | Olaso, Robert | Boland, Anne | Meyer, Vincent | Deleuze, Jean-François | Amouyel, P. | Munter, H. M. | Bourque, G. | Lathrop, M. | Frebourg, T. | Redon, Richard | Letenneur, L. | Dartigues, J.-F. | Martinaud, O. | Kalev, O. | Mehrabian, S. | Traykov, L. | Ströbel, T. | Le Ber, I. | Caroppo, P. | Epelbaum, S. | Jonveaux, T. | Pasquier, F. | Rollin-Sillaire, A. | Génin, E. | Guyant-Maréchal, L. | Kovacs, G. G. | Lambert, J.-C. | Hannequin, D. | Campion, D. | Rovelet-Lecrux, A.

Edité par CCSD ; Nature Publishing Group -

International audience. To assess the role of rare copy number variations in Alzheimer's disease (AD), we conducted a case-control study using whole-exome sequencing data from 522 early-onset cases and 584 controls. The most recurrent rearrangement was a 17q21.31 microduplication, overlapping the CRHR1, MAPT, STH and KANSL1 genes that was found in four cases, including one de novo rearrangement, and was absent in controls. The increased MAPT gene dosage led to a 1.6-1.9-fold expression of the MAPT messenger RNA. Clinical signs, neuroimaging and cerebrospinal fluid biomarker profiles were consistent with an AD diagnosis in MAPT duplication carriers. However, amyloid positon emission tomography (PET) imaging, performed in three patients, was negative. Analysis of an additional case with neuropathological examination confirmed that the MAPT duplication causes a complex tauopathy, including prominent neurofibrillary tangle pathology in the medial temporal lobe without amyloid-β deposits. 17q21.31 duplication is the genetic basis of a novel entity marked by prominent tauopathy, leading to early-onset dementia with an AD clinical phenotype. This entity could account for a proportion of probable AD cases with negative amyloid PET imaging recently identified in large clinical series.

Consulter en ligne

Suggestions

Du même auteur

High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease.

Archive ouverte | Pottier, Corinne | CCSD

International audience. Performing exome sequencing in 14 autosomal dominant early-onset Alzheimer disease (ADEOAD) index cases without mutation on known genes (amyloid precursor protein (APP), presenilin1 (PSEN1) a...

Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcification

Archive ouverte | Nicolas, G. | CCSD

International audience

Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing

Archive ouverte | Kunkle, B. W. | CCSD

International audience. Risk for late-onset Alzheimer's disease (LOAD), the most prevalent dementia, is partially driven by genetics. To identify LOAD risk loci, we performed a large genome-wide association meta-ana...

Chargement des enrichissements...